Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan
British Journal of Dermatology · 06.01.2026 · 194 (1) · 67-76
DOI: 10.1093/bjd/ljaf399 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 12.10.2025. Verfasst von Alex M Trafford und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Heal…. Hauptthemen laut MEDLINE: Psoriasis, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International League of Dermatological Societies, Atlas.
Abstract (Originalsprache)
Background
Psoriasis is a chronic inflammatory skin disease, and the risk of developing cancer has been postulated due to the presence of several plausible underlying mechanisms. Understanding the association between psoriasis and cancer is imperative to the provision of optimal psoriasis care.
Objectives
To examine the risk of developing cancer in individuals with psoriasis.
Methods
Population-based cohort studies were conducted in Denmark, England, Israel and Taiwan through the use of linked electronic health records. Individuals aged at least 18 years with a diagnosis of psoriasis in the country-specific study period were matched with up to six comparators with no record of psoriasis prior to the index date. Country-specific hazard ratios for the risk of cancer development overall and for 26 site-specific cancers between individuals with and without psoriasis were calculated through Cox regression. Country-specific estimates were pooled using random effects modelling.
Results
We included 702 022 individuals with psoriasis and 4 185 342 matched comparators. In models implicitly controlled for age, sex and calendar time by matching, there was a small association between psoriasis and cancer overall [pooled HR (pHR) 1.08, 95% confidence interval (CI) 1.04–1.13; I2 = 92.4%]. Adjustment for potential confounding factors resulted in a slight attenuation of risk (pHR 1.05, 95% CI 1.01–1.09; I2 = 81.2%). When restricted to those with moderate-to-severe psoriasis, the risk of cancer overall was slightly higher (pHR 1.16, 95% CI 1.04–1.28; I2 = 92.8%) than in confounder-adjusted models (pHR 1.09, 95% CI 1.03–1.15; I2 = 60.6%). Associations with psoriasis were present for oral cavity (pHR 1.29, 95% CI 1.12–1.47; I2 = 55.4%), pharynx (pHR 1.30, 95% CI 1.07–1.58; I2 = 58.4%), oesophagus (pHR 1.17, 95% CI 1.03–1.33; I2 = 56.6%), liver (pHR 1.53, 95% CI 1.33–1.77; I2 = 75.1%), pancreas (pHR 1.09, 95% CI 1.02–1.17; I2 = 0.0%), kidney (pHR 1.19, 95% CI 1.11–1.27; I2 = 0.0%), bladder (pHR 1.13, 95% CI 1.06–1.20; I2 = 28.7%) and keratinocyte cancers (pHR 1.37, 95% CI 1.16–1.63; I2 = 97.5%), and Hodgkin lymphoma (pHR 1.56, 95% CI 1.16–2.11; I2 = 69.7%), non-Hodgkin lymphoma (pHR 1.16, 95% CI 1.07–1.26; I2 = 35.5%) and leukaemia (pHR 1.18, 95% CI 1.08–1.29; I2 = 41.9%). Site-specific associations generally persisted, with slight risk exacerbations and additional associations for lung and ovarian cancers, when limited to people with moderate-to-severe psoriasis.
Conclusions
Psoriasis was associated with an increased risk of developing 14 of 26 investigated site-specific cancers, including cancers with a poor prognosis, such as liver, lung and oesophageal cancer. Our findings can be used to reinforce cancer prevention strategies in psoriasis care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centr…
- Department of Quality Measurements and Research, Clalit Health Services, Tel Aviv, Israel.
- Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK.
ORCID-Profile: Alex M Trafford, Yochai Schonmann, Teng-Chou Chen, Alexander Egeberg, Rosa Parisi, Evangelos Kontopantelis, Martin K Rutter, Li-Chia Chen, Tjeerd van Staa, Meng-Sui Lee, Khalaf Kridin, Arnon D Cohen, Kin-Wei A Chan, Alison K Wright, Christopher E M Griffiths, Darren M Ashcroft
Förderung
- International League of Dermatological Societies
- Atlas
Zitieren
APA
Trafford, A. M., Schonmann, Y., Chen, T. C., Egeberg, A., Parisi, R., Kontopantelis, E., Wang, T. C., Rutter, M. K., Chen, L. C., van Staa, T., Lee, M. S., Kridin, K., Cohen, A. D., Chan, K. A., Wright, A. K., Griffiths, C. E. M., & Ashcroft, D. M. (2026). Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan. British Journal of Dermatology, 194(1), 67-76. https://doi.org/10.1093/bjd/ljaf399
Vancouver
Trafford AM, Schonmann Y, Chen TC, Egeberg A, Parisi R, Kontopantelis E, et al. Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan. British Journal of Dermatology. 2026;194(1):67-76. doi:10.1093/bjd/ljaf399
BibTeX
@article{Trafford2026,
author = {Trafford, Alex M and Schonmann, Yochai and Chen, Teng-Chou and Egeberg, Alexander and Parisi, Rosa and Kontopantelis, Evangelos and Wang, Ting-Chun and Rutter, Martin K and Chen, Li-Chia and van Staa, Tjeerd and Lee, Meng-Sui and Kridin, Khalaf and Cohen, Arnon D and Chan, Kin-Wei A and Wright, Alison K and Griffiths, Christopher E M and Ashcroft, Darren M},
title = {Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan},
journal = {British Journal of Dermatology},
year = {2026},
volume = {194},
number = {1},
pages = {67--76},
doi = {10.1093/bjd/ljaf399}
}
EUVIMED